Nalaganje...
Maybe we don't know JAK?
The cornerstone for precision medicine is the development of robust biomarkers that reflect molecular phenotypes and therapeutic vulnerabilities in disease. We recently described Janus kinase-2 (JAK2)-specific inhibition as a therapeutic opportunity in triple negative breast cancers with 9p24 amplif...
Shranjeno v:
| izdano v: | Mol Cell Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4972112/ https://ncbi.nlm.nih.gov/pubmed/27652332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2016.1192713 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|